Category - Feature

Feature

Intellijoint Surgical setting new standard in surgical 3D navigation

By Len Zehrs Closely-held Intellijoint Surgical plans to improve patients’ lives by providing every orthopaedic surgeon with their surgical 3D solution that provides real-time intraoperative measurements to ensure...

July 3, 2018

Feature

Kardium seeking CE Mark for breakthrough treatment of atrial fibrillation

By Len Zehrs Closely-held Kardium hopes to receive marketing approval in Europe in the fourth quarter of 2018 and launch its breakthrough Globe mapping and ablation system of cardiac tissue for the treatment of atrial...

June 26, 2018

Feature

Imagin Medical taking bladder cancer imaging to next level

By Len Zehrs Imagin Medical’s (CSE:IME; OTC:IMEXF) i/Blue Imaging System is expected to improve physicians’ ability to detect bladder cancer with minimally invasive endoscopes and reduce recurrence by dramatically...

June 19, 2018

Feature

XOR Labs pioneering technology to expand lung transplantation

By Len Zehrs Closely-held XOR Labs hopes to dramatically increase the number of lungs suitable for transplantation with its Ex-Vivo Lung Perfusion (EVLP) technology. “Only about 20 out of every 100 donated lungs are...

June 12, 2018

Feature

NanoSphere spearheads delivery of medical nano-encapsulated THC/CBD

By Len Zehrs NanoSphere Health Sciences (CSE:NSHS; OTC:NSHSF) has developed a newly-patented delivery technology that increases the bioavailability and bioactivity of its Evolve line of gel-like cannabinoids for the...

June 5, 2018

Feature

Gecko Biomedical readies rapid acceleration of polymer platform

By Melane Sampson Since developing and validating SETALUM, a versatile vascular sealant in 2013, closely-held, Paris-based Gecko Biomedical is now poised to seek FDA approval for SETALUM, validate new programs, and open...

May 29, 2018

Feature

Nanobiotix pioneering nanomedicine in new paradigm against cancer

By Len Zehrs France’s Nanobiotix (Euronext:NANO) is hoping to change the paradigm for cancer treatment with a single nanomedicine applicable across oncology for millions of patients. “What differentiates us is that we...

May 15, 2018

Feature

CellAegis to complete enrolment in U.S. autoRIC trial by end of 2018

By Len Zehrs In addition to several large ongoing investigator-sponsored studies in Europe and Canada using its autoRIC device for automated remote ischemic conditioning (RIC), closely-held CellAegis Devices expects its...

May 8, 2018

Feature

Aimmune readies filing for FDA approval of peanut allergy treatment

By Len Zehrs On the heels of positive data from its PALISADE pivotal trial, Aimmune Therapeutics (NASDAQ:AIMT) plans to submit a biologics license application with the FDA by the end of 2018 for its peanut allergy...

May 1, 2018

Feature

Cyclica offers Pharma a novel cloud platform to increase R&D productivity

By Len Zehrs During the past four years, closely-held Cyclica has developed and validated a patented structure-based and AI-augmented proteome-screening platform, known as Ligand Express. “The platform enables critical...

April 24, 2018

Category - Feature

Subscribe